4′-羟基汉黄芩素通过抑制Gas6/Axl-PI3K/AKT信号减弱肝细胞癌进展
本研究探讨黄芩来源黄酮4′-羟基汉黄芩素对肝细胞癌的抗肿瘤作用及机制。体外实验显示其抑制HCC细胞增殖、迁移、侵袭,诱导G1期阻滞、凋亡和衰老;机制上降低Gas6和Axl表达、抑制PI3K/AKT活化。小鼠异种移植模型中显著减少肿瘤生长,疗效与索拉非尼相当,无明显肝毒性。
要点
- 4′-羟基汉黄芩素抑制HCC细胞增殖、迁移、侵袭并诱导凋亡和衰老。
- 其作用至少部分通过抑制Gas6/Axl-PI3K/AKT信号轴实现。
- 体内抑瘤疗效与索拉非尼相当且无明显肝毒性。
核心结论
- 4′-羟基汉黄芩素至少部分通过抑制Gas6/Axl-PI3K/AKT信号轴抑制肝细胞癌进展。
- 支持其作为天然治疗候选物进一步开发。
研究设计与样本
- 使用人HCC细胞进行体外功能实验。
- 采用全转录组测序、蛋白质印迹、定量PCR、分子对接和热位移分析探索机制。
- 在小鼠异种移植模型中进一步检测抗肿瘤疗效和安全性。
主要发现
- 4′-羟基汉黄芩素显著抑制HCC细胞增殖、迁移和侵袭。
- 诱导G1期阻滞、凋亡和衰老。
- 转录组和分子分析确定Axl为关键受影响靶点。
- 4′-羟基汉黄芩素降低Gas6和Axl表达,抑制PI3K/AKT活化,下调细胞周期和EMT相关蛋白。
- 分子对接预测4′-羟基汉黄芩素与Axl潜在相互作用,热位移分析支持该预测;Axl过表达部分逆转其抑制作用。
关键数值与推荐
- 体外实验显示4′-羟基汉黄芩素显著抑制HCC细胞增殖、迁移和侵袭。
- 诱导G1期阻滞、凋亡和衰老。
- 降低Gas6和Axl表达,抑制PI3K/AKT活化。
- 体内显著减少肿瘤生长,疗效与索拉非尼相当,无明显肝毒性。
临床怎么用
- 作为天然候选物,支持进一步开发用于肝细胞癌治疗。
- 机制上靶向Gas6/Axl-PI3K/AKT信号轴可能为HCC治疗提供新策略。
局限性
- Axl过表达仅部分逆转抑制作用,提示涉及Axl依赖和其他通路。
- 机制研究主要基于体外和动物模型,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
4′-Hydroxywogonin, a flavonoid derived from Scutellaria baicalensis, inhibits hepatocellular carcinoma progression partly by suppressing Gas6/Axl-PI3K/AKT signaling, inducing cell cycle arrest and apoptosis, and reducing metastatic potential. It also suppresses xenograft tumor growth without evident hepatotoxicity. ABSTRACT 4′-Hydroxywogonin, a bioactive flavonoid derived from Scutellaria baicalensis, has reported anti-inflammatory and anticancer activities; however, its therapeutic potential and molecular mechanism in hepatocellular carcinoma (HCC) remain unclear. This study investigated the anti-tumor effects of 4′-hydroxywogonin and its regulatory role in Gas6/Axl-associated signaling. Human HCC cells were used to evaluate proliferation, migration, invasion, cell cycle distribution, apoptosis, senescence, and epithelial-mesenchymal transition. Whole-transcriptome sequencing, western blotting, quantitative polymerase chain reaction, molecular docking, and thermal shift analysis were performed to explore the underlying mechanism, and antitumor efficacy and safety were further examined in a mouse xenograft model. 4′-Hydroxywogonin significantly inhibited HCC cell proliferation, migration, and invasion, while inducing G1-phase arrest, apoptosis, and senescence. Transcriptomic and molecular analyses identified Axl as a key affected target. 4′-Hydroxywogonin reduced Gas6 and Axl expression, suppressed PI3K/AKT activation, and downregulated cell cycle and epithelial-mesenchymal transition (EMT)-related proteins. Molecular docking predicted a potential interaction between 4′-hydroxywogonin and Axl, which was supported by thermal shift analysis. Axl overexpression partially rescued the inhibitory effects of 4′-hydroxywogonin, suggesting involvement of Axl-dependent and additional pathways. In vivo, 4′-hydroxywogonin markedly reduced tumor growth with efficacy comparable to sorafenib and without evident hepatotoxicity. These findings indicate that 4′-hydroxywogonin suppresses HCC progression, at least in part, through inhibition of the Gas6/Axl-PI3K/AKT signaling axis, supporting its further development as a natural therapeutic candidate.
引用
- Phytotherapy Research:4′‐Hydroxywogonin Attenuates Hepatocellular Carcinoma Progression by Suppressing Gas6/Axl‐PI3K/AKT Signaling
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。